Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis [PDF]
Frontiers in Cardiovascular Medicine, 2021 Aims: Evidence-based guidelines for heart failure management depend mainly on current left ventricular ejection fraction (LVEF). However, fewer studies have examined the impact of prior LVEF.
Xinxin Zhang +9 more
doaj +2 more sources
Heart failure with mid-range ejection fraction. Where are we today? [PDF]
Българска кардиология, 2021 Bulgarian Society of Cardiology adhere to the European Guidelines on Heart Failure (HF). The fi nalized studies and many debates and analyses after 2016 are prerequisite to creation of a new guideline for diagnosis and management on these patients.
Tzvetana Katova
doaj +4 more sources
ST2 in heart failure with reduced and mid-range ejection fraction: clinical and instrumental relationships and prognostic value [PDF]
Наука и инновации в медицине, 2021 Objectives to determine the clinical and instrumental relationships and prognostic value of sST2 in chronic heart failure with reduced and mid-range ejection fraction of ischemic etiology. Material and methods.
Natalya V. Kompanets +2 more
doaj +2 more sources
Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition [PDF]
Cardiac Failure Review, 2020 The recent definition of an intermediate clinical phenotype of heart failure (HF) based on an ejection fraction (EF) of between 40% and 49%, namely HF with mid-range EF (HFmrEF), has fuelled investigations into the clinical profile and prognosis of this ...
Davide Margonato +6 more
doaj +2 more sources
Arquivos Brasileiros de CardiologiaHeart failure predisposes to an increased risk of silent cerebral infarction, and data related to left ventricular ejection fraction are still limited.
Márcia Maria Carneiro Oliveira +7 more
doaj +2 more sources
Heart failure with mid‐range ejection fraction: characterization of patients from the PINNACLE Registry® [PDF]
ESC Heart Failure, 2019 Aims Guidelines for management of patients with heart failure with mid‐range ejection fraction [HFmrEF; left ventricular EF (LVEF) 41–49%] do not exist. Disagreement exists whether HFmrEF should be considered a distinct group. The aim of this study is to
Nasrien E. Ibrahim +7 more
doaj +2 more sources
Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction [PDF]
ESC Heart Failure, 2020 Aims Spironolactone has been shown to improve outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). We investigated whether the discharge use of spironolactone could be associated with better long‐term outcomes among patients ...
Nobuyuki Enzan +6 more
doaj +2 more sources
Heart failure with mid-range ejection fraction: Current evidence and uncertainties [PDF]
Monaldi Archives for Chest Disease, 2019 Heart failure (HF) with mid-range ejection fraction (HFmrEF) has been conceptualized by the European Society of Cardiology guidelines with the aim of stimulating research to fill a gap in knowledge: whether such a condition exists as a distinct ...
Raffaele Martone +2 more
doaj +2 more sources
Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction [PDF]
ESC Heart Failure, 2021 Aims Current evidence about the effect of angiotensin receptor blocker (ARB) on the outcome of heart failure with mid‐range ejection fraction (HFmrEF) is lacking.
Bin Wang +6 more
doaj +2 more sources
Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines [PDF]
ESC Heart Failure, 2020 Currently, the assessment of left ventricular ejection fraction (LVEF) is the cornerstone of the classification of patients with heart failure (HF). The mid‐range LVEF (HFmrEF) category was identified in an attempt to uncover specific characteristics of ...
Luca Branca +3 more
doaj +2 more sources